Guest guest Posted February 25, 2008 Report Share Posted February 25, 2008 http://www.ingentaconnect.com/content/bsc/ajg/2008/00000103/00000002/art00024;jsessionid=400suq9qs83dj.alexandra Gut Microbes in Crohn's Disease: Getting to Know You Better? Authors: , Seamus J.1; Ullman, A.2; Abreu, T.2 Source: The American Journal of Gastroenterology, Volume 103, Number 2, February 2008 , pp. 397-398(2) Publisher: Blackwell Publishing Abstract: Biomarkers in inflammatory bowel disease (IBD) are needed to help in disease diagnosis, prognosis, and assessment of disease activity. The best serologic markers to date measure antibody responses to normal commensal flora. These antibody responses can provide prognostic information as well as clues to disease pathogenesis. There remains room for additional biomarkers to clarify the diagnosis for certain patients with indeterminate colitis or small bowel Crohn's disease (CD) with protean manifestations. In this issue of the Journal, and colleagues describe the presence of antibodies against Bacteroides vulgatus in CD patients. This additional marker may complement existing disease markers. Future studies should address whether these antibodies can help categorize patients with indeterminate colitis or predict severity of CD. (Am J Gastroenterol 2008;103:397-398) Document Type: Research article DOI: 10.1111/j.1572-0241.2007.01571.x Affiliations: 1: Daisy Hill Hospital, Newry, Northern Ireland 2: Mount Sinai School of Medicine, New York, New York Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.